Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

OVER 20 people developed a potentially paralysing illness after getting the respiratory syncytial virus (RSV) vaccine. The UK ...

Key Takeaways High-risk adults as young as 50 are now eligible for the RSV vaccineThe update follows advice from now-deposed ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

The Vaccine Integrity Project will convene experts to assess the evidence on influenza, RSV, and Covid-19 to equip clinicians ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday to recommend Americans ...

Session ID: 2025-07-03:9a61974b939236f32b419e45 Player Element ID: V3f69f3ef_05ce_43e7_acbe_c951afabbbb5_6374131301112 ...

RSV hospitalizations were also down by about 19%. During the 2024-25 season, there were 1,269 hospitalizations due to RSV, as of the week ending in June 7, compared to 1,567 in 2023-24.

In China, RSV accounted for an estimated 3.5 million ALRTI cases and up to 950,000 hospitalizations in 2019-nearly one-quarter of the global burden.